ATXI Net Margin

The Net Margin of Avenue Therapeutics Inc (ATXI) is -207.19%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

ATXI Net Margin - Historical Value

Date	Value
2025-12-31	-207.19%

ATXI Net Margin - Peers Comparison

Ticker	Name	Value
KHRN.V	Khiron Life Sciences Corp	-258.92%
MRK	Merck & Co Inc	28.08%
XPHY.CN	Xphyto Therapeutics Corp	-7203.18%
BAMM.CN	Body and Mind Inc	-92.14%
EBM.V	Eastwood Bio-Medical Canada Inc	-42.55%
HUGE.CN	FSD Pharma Inc	-19519.39%
BMY	Bristol-Myers Squibb Co	14.64%
CANN.CN	Heritage Cannabis Holdings Corp	-67.45%
EYEN	Eyenovia Inc	-86882.51%
FLWR.V	Flowr Corp	-692.68%
PFE	Pfizer Inc	12.42%
COCP	Cocrystal Pharma Inc	-480.10%
CTLT	Catalent Inc	-23.81%
FONE.CN	Flower One Holdings Inc	-41.89%
NDVA.V	Indiva Ltd	-13.09%
ALID	Allied Corp	-4134.10%
CRDL.TO	Cardiol Therapeutics Inc	-39550.00%
RPRX	Royalty Pharma PLC	32.42%
PCSA	Processa Pharmaceuticals Inc	-6720.00%
ZTS	Zoetis Inc	28.23%
ASP.TO	Acerus Pharmaceuticals Corporation	-1594.39%
COOL.CN	Core One Labs Inc	-3485.34%
EVOK	Evoke Pharma Inc	-52.22%
JNJ	Johnson & Johnson	28.46%
VTRS	Viatris Inc	-24.58%
CURR	CURRENC Group Inc	-85.01%
ELAN	Elanco Animal Health Inc	-4.92%
NGW.CN	Next Green Wave Holdings Inc	27.40%
SHWZ	Medicine Man Technologies Inc	-20.03%
LLY	Eli Lilly and Co	31.67%
PRPH	Prophase Labs Inc	-788.24%
ROMJ.V	Rubicon Organics Inc	1.77%